Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Harmony Biosciences Holdings
Harmony Biosciences Holdings
(HRMY)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Wakix
Pitolisant
2019-08-14
2026-2030
Obstructive sleep apnea
,
Narcolepsy
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pitolisant
narcolepsy
,
myotonic dystrophy
,
disorders of excessive somnolence
,
sleepiness
,
prader-willi syndrome
,
idiopathic hypersomnia
,
syndrome
,
restless legs syndrome
,
psychomotor agitation
,
cataplexy
,
pregnancy rate
Losartan
essential hypertension
,
hypertension
,
insulin resistance
,
metabolic syndrome
,
overweight
Aspartame
neuroendocrine tumors
Clemizole
syndrome
,
myoclonic epilepsies
,
lennox gastaut syndrome
Zyn002
drug interactions
Gluconorm
healthy volunteers/patients
,
drug interactions
,
neoplasms
,
overweight
,
mitochondrial diseases
,
stroke
,
hypersensitivity
,
parkinson disease
,
recurrence
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
prostatic neoplasms
,
gastrointestinal stromal tumors
,
lymphoma
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
malaria
,
rheumatoid arthritis
,
arthritis
,
sickle cell anemia
,
hyperuricemia
,
renal insufficiency
,
hyperglycemia
,
heart failure
,
diabetes complications
,
morbid obesity
,
obesity
,
bariatric surgery
,
pancreatitis
,
pancreatic neoplasms
,
type 1 diabetes mellitus
,
prediabetic state
,
glucose intolerance
,
exocrine pancreatic insufficiency
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use